What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Gene
The scientist’s investigation covers issues in Medulloblastoma, Surgery, Cancer research, Pathology and Glioma.
His Medulloblastoma study incorporates themes from Cancer, Clinical trial, Bioinformatics, Molecular biology and Pediatrics.
His Surgery research is multidisciplinary, incorporating elements of Epilepsy surgery, Electroencephalography and Epilepsy.
His research investigates the connection between Cancer research and topics such as Epigenetics that intersect with issues in Epigenomics and DNA methylation.
His study on Pathology also encompasses disciplines like
- Oncology which intersects with area such as Cohort,
- Internal medicine that connect with fields like Endocrinology.
He works mostly in the field of Glioma, limiting it down to topics relating to Cell culture and, in certain cases, Astrocyte, as a part of the same area of interest.
His most cited work include:
- Nanoparticle-mediated cellular response is size-dependent (1967 citations)
- Medulloblastoma Comprises Four Distinct Molecular Variants (888 citations)
- Mutations in SUFU predispose to medulloblastoma (659 citations)
What are the main themes of his work throughout his whole career to date?
James T. Rutka mainly focuses on Surgery, Pathology, Epilepsy, Cancer research and Medulloblastoma.
He interconnects Radiology and Pediatrics in the investigation of issues within Surgery.
As part of his studies on Pathology, James T. Rutka often connects relevant areas like Cell culture.
His study in Epilepsy is interdisciplinary in nature, drawing from both Electroencephalography and Magnetoencephalography.
His research in Cancer research is mostly concerned with Glioma.
The study incorporates disciplines such as Cancer, Internal medicine, Oncology and Bioinformatics in addition to Medulloblastoma.
He most often published in these fields:
- Surgery (20.73%)
- Pathology (20.88%)
- Epilepsy (16.06%)
What were the highlights of his more recent work (between 2015-2021)?
- Epilepsy (16.06%)
- Neurosurgery (11.24%)
- Cancer research (16.06%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Epilepsy, Neurosurgery, Cancer research, Surgery and Epilepsy surgery.
His Epilepsy study combines topics in areas such as Anesthesia, Magnetic resonance imaging, Pediatrics and Magnetoencephalography.
In his study, which falls under the umbrella issue of Magnetic resonance imaging, Pathology is strongly linked to Blood–brain barrier.
The concepts of his Cancer research study are interwoven with issues in Carcinogenesis, Epigenetics and Drug delivery.
His studies link Odds ratio with Surgery.
James T. Rutka focuses mostly in the field of Epilepsy surgery, narrowing it down to matters related to Cortical dysplasia and, in some cases, Sulcus.
Between 2015 and 2021, his most popular works were:
- Intertumoral Heterogeneity within Medulloblastoma Subgroups (402 citations)
- Divergent clonal selection dominates medulloblastoma at recurrence (196 citations)
- Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis (132 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Gene
His primary areas of investigation include Surgery, Epilepsy, Neurosurgery, Internal medicine and Oncology.
The various areas that he examines in his Surgery study include Radiology and Epilepsy surgery.
His Epilepsy research includes themes of Pediatrics and Magnetoencephalography.
His Internal medicine research is multidisciplinary, incorporating perspectives in Medulloblastoma, Pathology and BRAF V600E.
The Medulloblastoma study combines topics in areas such as Clinical trial, Bioinformatics, Gene expression profiling, Grading and Mass spectrometry.
His Glioma research is within the category of Cancer research.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
